{"id":"https://openalex.org/W2902990794","doi":"https://doi.org/10.1182/blood-2018-99-110734","title":"Targeting Immune Dysregulation in Childhood Evans Syndrome","display_name":"Targeting Immune Dysregulation in Childhood Evans Syndrome","publication_year":2018,"publication_date":"2018-11-29","ids":{"openalex":"https://openalex.org/W2902990794","doi":"https://doi.org/10.1182/blood-2018-99-110734","mag":"2902990794"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2018-99-110734","doi":"https://doi.org/10.1182/blood-2018-99-110734","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-110734","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084270546","display_name":"Amanda Bell Grimes","orcid":"https://orcid.org/0000-0003-2842-9266","observed_orcids":["https://orcid.org/0000-0003-2842-9266"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amanda Bell Grimes","raw_affiliation_strings":["Baylor College of Medicine, Department of Pediatrics, Section of Hematology/Oncology, Houston, TX","Texas Children's Cancer and Hematology Centers, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baylor College of Medicine, Department of Pediatrics, Section of Hematology/Oncology, Houston, TX","institution_ids":["https://openalex.org/I181547552"]},{"raw_affiliation_string":"Texas Children's Cancer and Hematology Centers, Houston, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082360373","display_name":"Taylor Kim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Taylor Kim","raw_affiliation_strings":["Baylor College of Medicine, Department of Pediatrics, Section of Hematology/Oncology, Houston, TX","Texas Children's Cancer and Hematology Centers, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baylor College of Medicine, Department of Pediatrics, Section of Hematology/Oncology, Houston, TX","institution_ids":["https://openalex.org/I181547552"]},{"raw_affiliation_string":"Texas Children's Cancer and Hematology Centers, Houston, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058672912","display_name":"Susan E. Kirk","orcid":"https://orcid.org/0000-0001-6709-5460","observed_orcids":["https://orcid.org/0000-0001-6709-5460"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Susan E. Kirk","raw_affiliation_strings":["Baylor College of Medicine, Department of Pediatrics, Section of Hematology/Oncology, Houston, TX","Texas Children's Cancer and Hematology Centers, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baylor College of Medicine, Department of Pediatrics, Section of Hematology/Oncology, Houston, TX","institution_ids":["https://openalex.org/I181547552"]},{"raw_affiliation_string":"Texas Children's Cancer and Hematology Centers, Houston, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034517358","display_name":"Michele P. Lambert","orcid":"https://orcid.org/0000-0003-0439-402X","observed_orcids":["https://orcid.org/0000-0003-0439-402X"]},"institutions":[{"id":"https://openalex.org/I1335321130","display_name":"Children's Hospital of Philadelphia","ror":"https://ror.org/01z7r7q48","country_code":"US","type":"funder","lineage":["https://openalex.org/I1335321130"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michele P. Lambert","raw_affiliation_strings":["Department of Pediatrics, Division of Hematology/Oncology, Children's Hospital of Philadelphia, Philadelphia, PA","Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Division of Hematology/Oncology, Children's Hospital of Philadelphia, Philadelphia, PA","institution_ids":["https://openalex.org/I1335321130"]},{"raw_affiliation_string":"Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027937488","display_name":"Rachael F. Grace","orcid":"https://orcid.org/0000-0001-7302-0449","observed_orcids":["https://orcid.org/0000-0001-7302-0449"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210166317","display_name":"Dana-Farber/Boston Children's Cancer and Blood Disorders Center","ror":"https://ror.org/05k11pb55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113","https://openalex.org/I4210117453","https://openalex.org/I4210166317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rachael F. Grace","raw_affiliation_strings":["Harvard Medical School, Boston, MA","Harvard Medical School, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Harvard Medical School, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210166317"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5057425979","display_name":"Jenny McDade Despotovic","orcid":"https://orcid.org/0000-0001-9569-3636","observed_orcids":["https://orcid.org/0000-0001-9569-3636"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jenny M. Despotovic","raw_affiliation_strings":["Baylor College of Medicine, Department of Pediatrics, Section of Hematology/Oncology, Houston, TX","Texas Children's Cancer and Hematology Centers, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baylor College of Medicine, Department of Pediatrics, Section of Hematology/Oncology, Houston, TX","institution_ids":["https://openalex.org/I181547552"]},{"raw_affiliation_string":"Texas Children's Cancer and Hematology Centers, Houston, TX","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5058672912"],"corresponding_institution_ids":["https://openalex.org/I181547552"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"132","issue":"Supplement 1","first_page":"3564","last_page":"3564"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11616","display_name":"Autoimmune and Inflammatory Disorders Research","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/evans-syndrome","display_name":"Evans syndrome","score":0.9769999980926514},{"id":"https://openalex.org/keywords/pediatric-patients","display_name":"pediatric patients","score":0.6930000185966492},{"id":"https://openalex.org/keywords/immune-dysregulation","display_name":"immune dysregulation","score":0.796999990940094},{"id":"https://openalex.org/keywords/autoimmune-cytopenia","display_name":"autoimmune cytopenia","score":0.8989999890327454},{"id":"https://openalex.org/keywords/autoimmune-hemolytic-anemia","display_name":"autoimmune hemolytic anemia","score":0.9679999947547913},{"id":"https://openalex.org/keywords/immune-thrombocytopenic-purpura","display_name":"idiopathic thrombocytopenic purpura","score":0.9919999837875366},{"id":"https://openalex.org/keywords/autoimmune-neutropenia","display_name":"autoimmune neutropenia","score":0.953000009059906},{"id":"https://openalex.org/keywords/autoimmune-lymphoproliferative-syndrome","display_name":"autoimmune lymphoproliferative syndrome","score":0.9639999866485596},{"id":"https://openalex.org/keywords/common-variable-immunodeficiency","display_name":"common variable immunodeficiency","score":0.9340000152587891},{"id":"https://openalex.org/keywords/systemic-lupus-erythematosus","display_name":"systemic lupus erythematosus","score":0.8970000147819519},{"id":"https://openalex.org/keywords/diagnostic-rate","display_name":"diagnostic rate","score":0.45100000500679016},{"id":"https://openalex.org/keywords/immunomodulatory-therapy","display_name":"immunomodulatory therapy","score":0.7570000290870667},{"id":"https://openalex.org/keywords/treatment-outcomes","display_name":"treatment outcomes","score":0.5690000057220459},{"id":"https://openalex.org/keywords/refractory-disease","display_name":"refractory disease","score":0.4560000002384186}],"concepts":[{"id":"https://openalex.org/C2780194698","wikidata":"https://www.wikidata.org/wiki/Q6005429","display_name":"Immune dysregulation","level":3,"score":0.8599821925163269},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7928888201713562},{"id":"https://openalex.org/C2781128166","wikidata":"https://www.wikidata.org/wiki/Q3109873","display_name":"Evans syndrome","level":4,"score":0.7579566240310669},{"id":"https://openalex.org/C2777385706","wikidata":"https://www.wikidata.org/wiki/Q28814","display_name":"Autoimmune hemolytic anemia","level":3,"score":0.7520662546157837},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.605094850063324},{"id":"https://openalex.org/C2778959938","wikidata":"https://www.wikidata.org/wiki/Q1151300","display_name":"Autoimmune lymphoproliferative syndrome","level":5,"score":0.5814012885093689},{"id":"https://openalex.org/C2776433325","wikidata":"https://www.wikidata.org/wiki/Q1472818","display_name":"Common variable immunodeficiency","level":3,"score":0.46806254982948303},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.468049019575119},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.4622952342033386},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4558720290660858},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.4434337913990021},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.44038018584251404},{"id":"https://openalex.org/C163764329","wikidata":"https://www.wikidata.org/wiki/Q785022","display_name":"Autoantibody","level":3,"score":0.43631523847579956},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.17444998025894165},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.1345406174659729},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.08683383464813232},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C3031857","wikidata":"https://www.wikidata.org/wiki/Q1649375","display_name":"Fas receptor","level":4,"score":0.0},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2018-99-110734","doi":"https://doi.org/10.1182/blood-2018-99-110734","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-110734","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3127131116","https://openalex.org/W2962225575","https://openalex.org/W3165140158","https://openalex.org/W2782625694","https://openalex.org/W7163710515","https://openalex.org/W3048653791","https://openalex.org/W1915803358","https://openalex.org/W2803122496","https://openalex.org/W4411027551","https://openalex.org/W7133297189"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Evans":[2],"Syndrome":[3],"(ES)":[4],"describes":[5],"the":[6,97,143,178,502,536,580,584],"simultaneous":[7],"or":[8,13,279,292,620,639,650,673],"sequential":[9],"occurrence":[10],"of":[11,59,70,145,170,190,366,385,404,410,435,556,565,582,606,618,637,648,671],"2":[12,261],"more":[14,66,83,98,324,499,585],"autoimmune":[15,20,30,78,102,263,391,542],"cytopenias":[16,264],"-":[17,33,246,257,387],"most":[18],"often":[19,36,500],"hemolytic":[21],"anemia":[22],"(AIHA)":[23],"and":[24,40,82,110,131,147,157,183,196,207,217,273,399,454,470,492,596],"immune":[25,71,85,127,379,405,418,442,483,506,549,559,587],"thrombocytopenia":[26],"(ITP),":[27],"but":[28,53],"also":[29],"neutropenia":[31],"(AIN)":[32],"which":[34,589],"are":[35,138,160],"refractory":[37],"to":[38,49,175,202,205,211,218,298,307,320,344,371,527,538,598],"therapy":[39],"chronic":[41],"in":[42,56,124,153,164,200,285,383,414,438,501,517,525,575,655],"nature.":[43],"Historically,":[44],"ES":[45,122,152,232,361,412,436,553,577],"has":[46],"been":[47],"attributed":[48],"idiopathic":[50],"autoantibody":[51],"production,":[52],"recent":[54,116,242],"advances":[55],"our":[57],"understanding":[58],"this":[60,168,194,604],"disease":[61,543],"have":[62],"revealed":[63],"associations":[64],"with":[65,193,260,287,360,364,389,394,397,401,481,504,535],"well-described":[67],"underlying":[68,126,146,482,505,558],"disorders":[69,87,403],"regulation":[72,406],"when":[73],"properly":[74],"investigated.":[75],"These":[76],"include":[77],"lymphoproliferative":[79],"syndrome":[80],"(ALPS)":[81],"novel":[84],"dysregulation":[86,128,380,419,484,507,550,560,588],"such":[88],"as":[89,105,265,353],"Cytotoxic":[90],"T":[91],"Lymphocyte":[92],"Antigen-4":[93],"(CTLA-4)":[94],"defects,":[95],"among":[96,121,167,186,479,529,603],"historically":[99],"well-known":[100],"systemic":[101,106,390,541],"diseases":[103],"(such":[104],"lupus":[107],"erythematosus":[108],"[SLE])":[109],"common":[111],"variable":[112],"immunodeficiency":[113],"(CVID).":[114],"Importantly,":[115],"data":[117],"shows":[118],"improved":[119,599],"outcomes":[120,166,185,602],"patients":[123,192,233,249,359,386,413,437],"whom":[125,133,415,439,518],"is":[129,573],"identified":[130,382,422,485,508],"for":[132,214,346,540,547,592],"appropriately":[134],"targeted":[135,593],"immunomodulating":[136],"treatments":[137],"then":[139],"utilized.":[140],"Despite":[141],"this,":[142],"majority":[144],"potentially":[148],"targetable":[149],"pathologies":[150],"driving":[151],"children":[154],"remain":[155],"undiagnosed;":[156],"treatment":[158,181,594],"strategies":[159,595],"therefore":[161],"empiric,":[162],"resulting":[163],"sub-optimal":[165],"population":[169,605],"patients.":[171,607],"Aims:":[172],"We":[173,224],"aim":[174],"better":[176,219],"describe":[177],"diagnostic":[179,209],"rates,":[180],"strategies,":[182],"clinical":[184,221],"a":[187,226,241,416,475,519],"large":[188,237],"cohort":[189],"pediatric":[191,231,411,576],"rare":[195],"poorly":[197],"studied":[198],"disease,":[199,392],"order":[201],"identify":[203],"barriers":[204],"appropriate":[206],"timely":[208],"investigation,":[210],"highlight":[212],"areas":[213],"future":[215],"research,":[216],"inform":[220],"practices.":[222],"Methods:":[223],"completed":[225],"retrospective":[227],"chart":[228],"review":[229],"including":[230],"followed":[234],"at":[235,474],"3":[236,396,400,425],"tertiary":[238],"centers":[239],"over":[240],"6-year":[243],"period":[244],"(2012":[245],"2018).":[247],"All":[248],"meeting":[250],"eligibility":[251],"criteria":[252],"(those":[253],"aged":[254],"6":[255],"months":[256],"21":[258],"years,":[259],"documented":[262],"defined":[266,352],"by":[267,562],"current":[268],"international":[269],"expert":[270],"committee":[271],"standards,":[272],"not":[274],"having":[275],"undergone":[276],"solid":[277],"organ":[278],"stem":[280],"cell":[281],"transplantation)":[282],"were":[283,296,330,362,472,496],"reviewed":[284],"accordance":[286],"IRB-approved":[288],"protocols.":[289],"Chi-squared":[290],"test":[291,295,317],"Fisher's":[293],"exact":[294],"utilized":[297,473],"compare":[299,308,321],"nonparametric":[300,309],"categorical":[301],"data.":[302,311],"Mann-Whitney":[303],"U-test":[304],"was":[305,318,342,351,381,421,444,522,531],"used":[306,319],"continuous":[310],"A":[312,339,349,569],"Kruskal-Wallis":[313],"one":[314],"way":[315],"ANOVA":[316],"ranks":[322],"between":[323],"than":[325,545],"two":[326],"categories.":[327],"Statistical":[328],"analyses":[329],"performed":[331],"using":[332],"SPSS":[333],"Statistics":[334],"24":[335],"(IBM,":[336],"Armonk,":[337],"NY).":[338],"Bonferroni":[340],"correction":[341],"applied":[343],"correct":[345],"multiple":[347],"comparisons.":[348],"p<0.05":[350],"statistically":[354,532],"significant.":[355],"Results:":[356],"48":[357],"eligible":[358],"identified,":[363],"length":[365],"follow-up":[367,428,447],"ranging":[368],"from":[369],"0":[370],"12":[372,388],"years":[373],"(median":[374],"=":[375,429,448],"2.7":[376],"years).":[377],"Underlying":[378],"46%":[384],"4":[393],"ALPS,":[395],"CVID,":[398],"other":[402,548],"(n=22).":[407],"Notably,":[408],"100%":[409],"definitive":[417],"disorder":[420,561],"required":[423,497],"\u2265":[424],"therapies":[426],"(mean":[427,446],"3.7":[430,566],"years),":[431],"vs.":[432,487,510],"only":[433],"58%":[434],"no":[440],"unifying":[441,520],"diagnosis":[443,521,528,539],"made":[445],"3.2":[449],"years)":[450],"[p=0.008].":[451],"Furthermore,":[452],"second-":[453],"third-line":[455],"immunomodulatory":[456,494],"agents":[457,495],"(including":[458],"mycophenolate,":[459],"hydroxychloroquine,":[460],"6-mercaptopurine,":[461],"belimumab,":[462],"ofatumumab,":[463],"abatacept,":[464],"rituximab,":[465],"sirolimus,":[466],"cyclosporine,":[467],"azathioprine,":[468],"danazol,":[469],"methotrexate)":[471],"significantly":[476,498],"higher":[477],"rate":[478],"those":[480,488,511,516],"(82%)":[486],"without":[489,512],"(31%)":[490],"[p=0.003];":[491],"\u22653":[493],"group":[503],"(32%)":[509],"(0%)":[513],"[p=0.016].":[514],"Among":[515],"made,":[523],"difference":[524],"time":[526,537],"groups":[530],"significant":[533],"(p=0.036),":[534],"shorter":[544],"that":[546],"disorders.":[551],"Overall,":[552],"preceded":[554],"identification":[555],"an":[557,563,615,634,645,668],"average":[564],"years.":[567],"Conclusion:":[568],"thorough":[570],"investigative":[571],"approach":[572],"necessary":[574],"patients,":[578],"given":[579],"importance":[581],"identifying":[583],"global":[586],"would":[590],"allow":[591],"lead":[597],"overall":[600],"long-term":[601],"Figure.":[608,609],"Disclosures":[610],"Lambert:":[611],"Bayer:":[612],"Membership":[613,632,643,666],"on":[614,633,644,667],"entity's":[616,635,646,669],"Board":[617,636,647,670],"Directors":[619,638,649,672],"advisory":[621,640,651,674],"committees;":[622,641,652,675],"Summus:":[623],"Consultancy;":[624,626,628,630,657],"Rigel:":[625],"Sysmex:":[627],"Shionogi:":[629],"Novartis:":[631],"Amgen:":[642],"Educational":[653],"Concepts":[654],"Medicine:":[656],"CSL:":[658],"Consultancy.":[659,678,686],"Grace:Agios":[660],"Pharmaceuticals:":[661,665,677],"Research":[662,680,683],"Funding;":[663,681,684],"Agios":[664,676],"Despotovic:Novartis:":[679],"AmGen:":[682],"Sanofi:":[685]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2018-12-11T00:00:00"}